Trial Profile
A phase II study of Ad-SGE-REIC
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 14 Dec 2021
Price :
$35
*
At a glance
- Drugs Ad5 SGE DKK3 gene therapy-Momotaro (Primary)
- Indications Malignant-mesothelioma
- Focus Therapeutic Use
- Sponsors Kyorin Pharmaceutical
- 30 Jul 2018 New trial record